Creation Of Sound Science Policy Hindered By Budget Debates

For too long, national debates on science and technology (S&T) policy have been conducted as a footnote to budget debates. Nagging and important issues, fundamental to the conduct and future of our national research and development (R&D) enterprise, have been left to languish while Congress debates artful accounting exercises that do not pencil out, budgets that are really Trojan horses for someone's ideological social blueprints, or "feel-good" proposals to increase spending on R&D

Written byRep. George Brown
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

For too long, national debates on science and technology (S&T) policy have been conducted as a footnote to budget debates. Nagging and important issues, fundamental to the conduct and future of our national research and development (R&D) enterprise, have been left to languish while Congress debates artful accounting exercises that do not pencil out, budgets that are really Trojan horses for someone's ideological social blueprints, or "feel-good" proposals to increase spending on R&D that have no basis in budgetary reality.

Left neglected by this myopic fixation on the need to balance the federal budget-a need generally recognized as a political and not an economic imperative-is a complicated set of issues affecting national S&T policy that requires immediate attention. The problem confronting the public- policy apparatus is akin to a transcendental equation. We are being asked to set a policy on S&T to lead the United States-and by inference much of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies